+44 (0)1865 595230
0 Items

Herpes Simplex

Herpes simplex virus (HSV-1) causes highly contagious infection, which is common and endemic throughout the world. Most HSV-1 infections are acquired during childhood, and infection is lifelong. The vast majority of HSV-1 infections are oral herpes, but a small proportion of HSV-1 infections may present as genital herpes. HSV-2 infection is widespread and is almost exclusively sexually transmitted, causing genital herpes. HSV-2 is the main cause of genital herpes and is lifelong and incurable.

The Native Antigen Company offers a range of both antigens and antibodies for research into both HSV-1 and HSV-2, including specific reagents that can distinguish between these infections.

Herpes Simplex Background

Human herpes simplex virus (HSV), also known as human herpes virus (HHV), is a large enveloped double stranded DNA virus that belongs to the Herpesviridae family, subfamily Alphaherpesvirinae. Human HSV exists as two distinct serotypes: herpes simplex virus type -1 (HSV-1 / HHV1) and type -2 (HSV-2 / HHV2). Both HSV-1 and HSV-2 are neurotrophic viruses that invade the central nervous system (CNS), where they replicate and have the capacity to establish a latent infection (Nicoll, MP et al).

HSV-1 and HSV-2 are primarily transmitted from human-to-human through contact with mucosal surfaces and damaged skin, which are common sites of primary HSV infection. However, the route and site of infection differs for each serotype with some reported overlap. Typically, HSV-1 is transmitted through oral-to-oral contact giving rise to infection of the lips, eyes and oropharyngeal mucosa, and can also present in the genital tract through oral-genital contact. HSV-2 tends to be sexually transmitted via contact with infected mucosa or damaged skin associated with the genital tract. In most cases, individuals infected with either HSV-1 or HSV-2 for the first time remain asymptomatic or present with painful blisters or ulcers at the site of infection.

HSV-1 establishes latency in the trigeminal ganglia, whereas HSV-2 tends to establish latency in the lumbar-sacral ganglia. Reactivation of either HSV-1 or HSV-2 can occur in immunosuppressed individuals or in seropositive individuals in response to a wide range of stimuli including periods of emotional and physical stress.

Both HSV-1 and HSV-2 are widespread, lifelong infections. Some symptoms of infection can be alleviated using antiviral medication, though no prophylactic vaccine currently exists for either HSV-1 or HSV-2 (WHO factsheet).

References

  1. Nicoll, MP et al. (2012). The molecular basis of herpes simplex virus latency. FEMS Microbiol Rev.36(3): 684–705.
  2. World Health Organisation – Herpes Simplex Virus factsheet

Herpes Simplex Antigens

We offer a range of native antigens for both HSV-1 and HSV-2. Virus preparations are derived from in vitro culture, with the option of a whole cell lysate or highly purified viral particles available. We also offer a preparation of purified gG2 protein, which is the only known protein that can serologically distinguish between HSV-1 and HSV-2 infections.

Herpes Simplex Antibodies

Our range of antibodies specific to herpes simplex virus includes a reagent specific for glycoprotein D, which binds to both HSV-1 and HSV-2, and an antibody that is highly specific for HSV-2.

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

Challenges to Effective Yellow Fever Diagnostics

Yellow fever is a haemorrhagic viral disease, transmitted by infected mosquitos in Africa and South America. While an effective vaccine is available, inadequate vaccination of endemic areas has made diagnostics a necessity to controlling ongoing outbreaks. However,...

Five Methods You Can Use to Overcome Zika-Dengue Cross-Reactivity

Cross-reactivity between the Zika and Dengue viruses in serological assays is one of the biggest challenges faced by the epidemiologists, academics and pharmaceutical companies trying to control the Zika epidemic, as it brings the quality and reliability of diagnostic...

Why Zika virus’s cross-reactivity with Dengue might be hampering your research

Given the impact of Zika, it’s no surprise that a global contingent of epidemiologists, academic researchers, and pharmaceutical companies are striving to develop effective disease control measures and treatments. One challenge currently hindering the...

How The Native Antigen Company responds to the WHO list of priority infectious diseases

In 2015, a broad group of public health and science experts gathered in Geneva to discuss emerging infectious diseases that are likely to cause future severe epidemics and public health emergencies. Organised by the World Health Organization (WHO), their aim was to...

Native Antigen release a panel of serotype specific monoclonal antibodies

  There are four distinct serotypes of Dengue Virus circulating around the world, causing Dengue fever infection which is the most important worldwide arboviral disease. There are nearly 400 million cases of Dengue annually, and around 25% present with so called...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

9 + 9 =

Live Customer Feedback